Johnson & Johnson Covid-19 Vaccine May Trigger Neurological Condition In Rare Cases, FDA To Add Warning
Johnson & Johnson To Soon Start Clinical Bridging Trials Of Its Single-Dose Covid-19 Vaccine In India: Report
